Toggle visibility Search & Display Options

Select All    Deselect All
 |   | 
Details
   print
  Records Links
Author Schreier, E.; Höhne, M.   
  Title Hepatitis C : Epidemiologie und Prävention Type Journal Article
  Year 2001 Publication Bundesgesundheitsblatt : Gesundheitsforschung : Gesundheitsschutz Abbreviated Journal  
  Volume 44 Issue Pages 554-561  
  Keywords health promotion; viral hepatitis; hepatitis C  
  Abstract  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication (up) Editor  
  Language German Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1436-9990 ISBN Medium  
  Area Expedition Conference  
  Notes Approved no  
  Call Number 50-02781 Serial 59752  
Permanent link to this record
 

 
Author Soriano, Vincent; Sulkowski, Mark; Bergin, Colm; Hatzakis, Angelos; Cacoub, Patrice; Katlama, Christine; Cargnel, Antonietta; Mauss, Stefan; Dieterich, Douglas; Moreno, Santiago; Ferrari, Carlo; Poynard, Thierry; Rockstroh, Jürgen url 
  Title Care of patients with chronic hepatitis C and HIV co-infection: recommendations from the HIV-HCV international Panel Type Journal Article
  Year 2002 Publication Aids Abbreviated Journal  
  Volume 16 Issue Pages 813-828  
  Keywords health promotion; viral hepatitis; hepatitis C; HIV infection; Aids  
  Abstract  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication (up) Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 0269-9370 ISBN Medium  
  Area Expedition Conference  
  Notes Approved no  
  Call Number 50-02764 Serial 59750  
Permanent link to this record
 

 
Author Leshel-Hauzeneder, Melanie   
  Title Sonderbericht Hepatitis C : Hepatitis-C-Infektionen ausheilen : Pegyliertes lnterferon -alfa- 2a schafft neue Perspektiven in Deutschland Type Journal Article
  Year 2003 Publication MMW : Fortschritte der Medizin Abbreviated Journal  
  Volume 145 Issue 26 Pages 52-53  
  Keywords health promotion; viral hepatitis; hepatitis C  
  Abstract  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication (up) Editor  
  Language German Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1438-3276 ISBN Medium  
  Area Expedition Conference  
  Notes Approved no  
  Call Number 50-02763 Serial 59749  
Permanent link to this record
 

 
Author Böttcher-Bühler, Eckhard; Szostecki, Carin   
  Title Sonderbericht Chronische Hepatitis C : Pegyliertes Interferon U-2a : Lebensqualitat steigt bei erfolgreicher Therapie deutlich an Type Journal Article
  Year 2002 Publication MMW : Fortschritte der Medizin Abbreviated Journal  
  Volume 144 Issue 48 Pages 52-53  
  Keywords health promotion; viral hepatitis; hepatitis C  
  Abstract  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication (up) Editor  
  Language German Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1438-3276 ISBN Medium  
  Area Expedition Conference  
  Notes Approved no  
  Call Number 50-02762 Serial 59748  
Permanent link to this record
 

 
Author Huber, Milo; Oppliger, Robert; Vernazza, Pietro; Schönbucher, Peter; Bertisch, Barbara; Meili, Daniel; Renner, Eberhard url 
  Title Therapie der Chronischen Hepatitis C in offiziellen Opiat Substitutionsprogrammen : Interferon alfa 2a in Kombination mit Ribavirin in hoher oder niedriger Dosis : eine offene, randomisierte Multizenterstudie Type Journal Article
  Year 2002 Publication Suchtmedizin in Forschung und Praxis Abbreviated Journal  
  Volume 4 Issue 2 Pages 84-85  
  Keywords hepatitis C  
  Abstract  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication (up) Editor  
  Language German Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1437-5567 ISBN Medium  
  Area Expedition Conference  
  Notes Der Artikel ist auf Seite 8 des pdfs. Approved no  
  Call Number 50-02759 Serial 59747  
Permanent link to this record
 

 
Author Huber, Milo; Weber, Rainer; Oppliger, Robert; Vernazza, Pietro; Schmid, Patrick; Schönbucher, Peter; Bertisch, Barbara; Meili, Daniel; Renner, Eberhard url 
  Title Interferon-alpha2a plus ribavirin 1000/1200 mg versus interferon-alpha2a plus ribavirin 600 mg for treatment of chronic hepatitis C among patients in opiate substitution programs : an open-label randomized multicenter trial : Korrekturexemplar Type Journal Article
  Year 2005 Publication Infection Abbreviated Journal  
  Volume 33 Issue 1 Pages 93-97  
  Keywords health promotion; viral hepatitis; hepatitis C  
  Abstract Background: Many intravenous opiate users are infected with hepatitis C virus (HCV) but few are treated. Although this complies with various guidelines, virtually no published evidence supports such a recommendation. Patients and Methods: In a multicenter study, HCV-infected patients in opiate maintenance treatment programs received interferon plus high- or low-dose ribavirin (1000/1200 mg or 600 mg). HIV-coinfected patients were not included. Endpoints were feasibility, efficacy, side effects, and reasons for dropout. Results: Of the 420 patients who tested positive for HCV, 27 (6%) were enrolled; 393 (94%) either failed to meet the inclusion criteria or refused treatment. Virologic end-of-treatment response was achieved in 12/27 patients, and sustained response in 13/27 (48%). Response depended on viral genotype, not ribavirin dose. The two doses of ribavirin did not differ in their side effects. Conclusion: In a small fraction of HCV-infected intravenous drug users in an opiate maintenance treatment program, antiviral therapy was feasible, safe and effective. The success rate was comparable to that achieved in controlled studies that excluded drug users.  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication (up) Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN ISBN Medium  
  Area Expedition Conference  
  Notes Der Entwurf dieses Artikel ist auf Deutsch vorhanden, allerdings ohne EndNote-Eintrag (vgl. zweites pdf-file). Approved no  
  Call Number 50-02758 Serial 59746  
Permanent link to this record
 

 
Author Davis, Gary L.; Rodrigue, James R. url 
  Title Treatment of chronic hepatitis C in active drug users Type Journal Article
  Year 2001 Publication The New England journal of medicine Abbreviated Journal  
  Volume 345 Issue 3; 19.07.2001 Pages 215-217  
  Keywords health promotion; viral hepatitis; hepatitis C  
  Abstract  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication (up) Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1533-4406 ISBN Medium  
  Area Expedition Conference  
  Notes Approved no  
  Call Number 50-02751 Serial 59744  
Permanent link to this record
 

 
Author Greub, Gilbert; Maziero, Annik; Kaufmann, Gilbert; Colombo, Carlo; Zysset, Frédéric; Ruef, Christian; Francioli, Patrick url 
  Title Expositions professionnelles au sang contaminé par le virus de l'hépatite C dans le secteur médical en Suisse, état à la fin de l'an 2000 Type Journal Article
  Year 2002 Publication Bulletin Abbreviated Journal  
  Volume Issue 40; 30.09.2002 Pages 692-696  
  Keywords health promotion; HIV infection; Aids; viral hepatitis; hepatitis C; Switzerland  
  Abstract Les professionnels de la santé sont exposés par leur activité au risque de transmission d’agents infectieux par le sang (VIH, VHB – virus de l’hépatite B, VHC – virus de l’hépatite C). La vaccination contre l’hépatite B a permis de diminuer considérablement les infections par ce virus dans le secteur sanitaire. Il n’existe en revanche pas de vaccination contre le VIH et le VHC. De 1997 à 2001, 6 infections par le VHC ont été rapportées en Suisse parmi le personnel de santé, soit 1,8% des expositions accidentelles à du sang VHC positif (séroconversions documentées). Une piqûre d’aiguille est à l’origine de tous les cas. Aucune transmission par exposition des muqueuses (bouche, yeux) n’a été mise en évidence. La déclaration systématique des accidents exposant au sang est un instrument essentiel pour améliorer la prévention et la prise en charge des expositions professionnelles au VHC.  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication (up) Editor  
  Language French Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1420-4266 ISBN Medium  
  Area Expedition Conference  
  Notes Auch auf Deutsch vorhanden: 50-02744 Approved no  
  Call Number 50-02745 Serial 59743  
Permanent link to this record
 

 
Author Greub, Gilbert; Maziero, Annik; Kaufmann, Gilbert; Colombo, Carlo; Zysset, Frédéric; Ruef, Christian; Francioli, Patrick url 
  Title Beruflich bedingte Blutexpositionen mit Hepatitis-C-Virus im Medizinalbereich in der Schweiz bis Ende 2000 Type Journal Article
  Year 2002 Publication Bulletin Abbreviated Journal  
  Volume Issue 40; 30.09.2002 Pages 692-696  
  Keywords health promotion; HIV infection; Aids; viral hepatitis; hepatitis C; Switzerland  
  Abstract Das Medizinalpersonal ist dem Risiko einer Übertragung von Infektionskrankheiten (HIV, Hepatitis B/C) durch Blut ausgesetzt. Dank der Hepatitis-B-Impfung wurden die Infektionen mit dem Hepatitis-B-Virus beim Medizinalpersonal wesentlich vermindert. Gegen HIV und Hepatitis C gibt es hingegen keine Impfung. Von 1997–2001 wurden in der Schweiz beim Medizinalpersonal sechs Übertragungen von Hepatitis-C-Viren gemeldet. Dies entspricht 1,8% der unfallbedingten Expositionen mit HCV-positivem Blut (dokumentierte Serokonversion). In allen Fällen ist ein Nadelstich die Ursache. Eine Übertragung über Schleimhäute (Mund, Augen) wurde nicht nachgewiesen. Möglichst vollständige Meldungen und die systematische Analyse der unfallbedingten Expositionen tragen dazu bei, die Präventionsmassnahmen und die Betreuung der exponierten Personen kontinuierlich zu verbessern.  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication (up) Editor  
  Language German Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN 1662-7350 ISBN Medium  
  Area Expedition Conference  
  Notes Aussi disponible en français: 50-02745 Approved no  
  Call Number 50-02744 Serial 59742  
Permanent link to this record
 

 
Author Dalgard, O.; Bjøro, K.; Hellum, K.; Myrvang, B.; Skaug, K.; Gutigard, B.; Bell, H.   
  Title Treatment of Chronic Hepatitis C in Injecting Drug Users: 5 Years' Follow-Up Type Journal Article
  Year 2002 Publication European addiction research Abbreviated Journal  
  Volume 8 Issue Pages 45-49  
  Keywords health promotion; viral hepatitis; hepatitis C  
  Abstract Aim of the Study: To assess the long-term hepatitis C (HCV) treatment outcome in former injecting drug users (IDUs). Materials and Methods: A long-term follow-up of 27 former IDUs who had been successfully treated for chronic hepatitis C was performed. These patients represented ailiDUs who had obtained a sustained virological response in a Norwegian HCV treatment trial. The patients had been treated with interferon-a alone or in combinatlon with ribavirin. At 5 years’ follow-up the 27 IDUs were retested for HCV RNA and risk behaviour for HCV transmission after treatment was assessed. In the control group ail 18 non-IDUs who had obtained a sustained virological response in the same treatment trial were included. Results: At follow-up 13-82 months (median 64) after the end of treatment only one case of probable reinfection was seen among the 27 IUDs. No reoccur- rence of HCV was observed in the control group. The IDU who was HCV RNA positive at follow-up had continued injecting drugs and reported frequent needle sharing. At follow-up HCV of genotype 1a was detected in contrast to genotype 1b before treatment indicating that this patient was reinfected with HCV. A return to injecting drug use occurred in 9 (33%) of 27 IDUs. Conclusion: The long-term outcome of HCV treatment in former IDUs was excellent. Despite frequent reinitiation of drug injection ail but 1 remained HCV RNA negative.  
  Address  
  Corporate Author Thesis  
  Publisher Place of Publication (up) Editor  
  Language English Summary Language Original Title  
  Series Editor Series Title Abbreviated Series Title  
  Series Volume Series Issue Edition  
  ISSN ISBN Medium  
  Area Expedition Conference  
  Notes Approved no  
  Call Number 50-02733 Serial 59741  
Permanent link to this record
Select All    Deselect All
 |   | 
Details
   print

Save Citations:
Export Records: